Showing results (71-80 of 357) with videos related to
Sort By:
Pageof 36
ACS Infectious Diseases|March 16, 2024
Synthesis, Stereochemical Resolution, and Analogue Synthesis of Variabiline, an Aporphine Alkaloid That Sensitizes <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> to ColistinHaoting Li, Ansley M Nemeth, Roberta J Melander, et al.ACS Infectious Diseases|May 11, 2025
Validation of a Cystic Fibrosis Co-Culture Model for the Identification of Dual Acting Compounds with Antibiotic and Antibiotic Adjuvant PropertiesAnne E Mattingly, Haoting Li, Roberta J Melander, et al.Biomolecular NMR Assignments|December 25, 2012
Chemical shift assignments and secondary structure prediction of the C-terminal domain of the response regulator BfmR from Acinetobacter baumanniiAndrew L Olson, Richele J Thompson, Christian Melander, et al.Antimicrobial Agents and Chemotherapy|March 10, 2010
Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agentsSteven A Rogers, Robert W Huigens, John Cavanagh, et al.ACS Infectious Diseases|June 12, 2018
New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumanniiBradley M Minrovic, David Jung, Roberta J Melander, et al.Biomolecular NMR Assignments|August 17, 2011
¹H, ¹³C, and ¹⁵N resonance assignments and secondary structure prediction of the full-length transition state regulator AbrB from Bacillus anthracisAndrew L Olson, Benjamin G Bobay, Christian Melander, et al.Expert Reviews in Molecular Medicine|February 12, 2009
Pharmaceutical approaches to eradication of persistent HIV infectionMary-Catherine Bowman, Nancie M Archin, David M MargolisPharmacotherapy|December 9, 2004
Atazanavir for the treatment of human immunodeficiency virus infectionAnthony J Busti, Ronald G Hall, David M MargolisViruses|August 26, 2023
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency PreventionCatherine A Lewis, David M Margolis, Edward P BrowneThe Journal of Infectious Diseases|April 19, 2008
Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cellsShailesh K Choudhary, Nancy M Archin, David M MargolisPageof 36